Prograf and Inflammatory bowel disease - a phase IV clinical study of FDA data

Summary:

Inflammatory bowel disease is reported as a side effect among people who take Prograf (tacrolimus), especially for people who are female, 50-59 old, have been taking the drug for 6 - 12 months also take Cellcept, and have Acne.

The phase IV clinical study analyzes which people have Inflammatory bowel disease when taking Prograf. It is created by eHealthMe based on reports of 41,725 people who have side effects when taking Prograf from the FDA, and is updated regularly.

What is Prograf?

Prograf has active ingredients of tacrolimus. It is often used in kidney transplant. eHealthMe is studying from 42,230 Prograf users. Check the latest studies of Prograf.

What is Inflammatory bowel disease?

Inflammatory bowel disease is found to be associated with 661 drugs and 865 conditions by eHealthMe. Check the latest studies of Inflammatory bowel disease.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 26, 2026

41,725 people reported to have side effects when taking Prograf.
Among them, 21 people (0.05%) have Inflammatory bowel disease.

Could Prograf cause Inflammatory bowel disease?

Among these 21 people:

How long have people been on Prograf when they have Inflammatory bowel disease? *

What is the gender of people who have Inflammatory bowel disease when taking Prograf? *

female: 75 %
male: 25 %

What is the age of people who have Inflammatory bowel disease when taking Prograf? *

What are other drugs people take besides Prograf? *

What are other side effects people have besides Inflammatory bowel disease? *

Weight Decreased: 5 people, 23.81%
Abdominal Pain: 5 people, 23.81%
Fever: 5 people, 23.81%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 4 people, 19.05%
Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall): 3 people, 14.29%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 3 people, 14.29%
Depression: 3 people, 14.29%
Haemoglobin Decreased: 3 people, 14.29%
Diarrhea: 3 people, 14.29%
Constipation: 3 people, 14.29%

What are the existing conditions these people have? *

Acne (skin problems that cause pimples): 4 people, 19.05%
Juvenile Rheumatoid Arthritis (joint inflammation in children due to systemic disease): 2 people, 9.52%
Autoimmune Hepatitis: 2 people, 9.52%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 1 person, 4.76%
Takayasu's Arteritis (an inflammation of the aorta -- the artery that carries blood from the heart to the rest of the body): 1 person, 4.76%
Genetic Polymorphism (natural variations in a gene, dna sequence, or chromosome that have no adverse effects on the individual and occur): 1 person, 4.76%
Familial Mediterranean Fever (genetic disease recurring attacks of abdominal pain, fever, pleurisy, arthritis, and rash): 1 person, 4.76%
Essential Hypertension (primary hypertension): 1 person, 4.76%
Cytomegalovirus Viraemia (cytomegalo virus in blood stream): 1 person, 4.76%
Cytomegalovirus Enterocolitis (virus infection of intestine and colon): 1 person, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Prograf and have Inflammatory bowel disease?

- Check whether Inflammatory bowel disease is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Prograf:

Prograf (42,230 reports)

Browse all side effects of Prograf:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Inflammatory bowel disease:

Inflammatory bowel disease (661 drugs)

Browse all the conditions that are associated with Inflammatory bowel disease:

Inflammatory bowel disease (865 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on tacrolimus (the active ingredients of Prograf) and Prograf (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.